WO2001050214A2 - Methods for collecting genetic material - Google Patents

Methods for collecting genetic material Download PDF

Info

Publication number
WO2001050214A2
WO2001050214A2 PCT/EP2000/013355 EP0013355W WO0150214A2 WO 2001050214 A2 WO2001050214 A2 WO 2001050214A2 EP 0013355 W EP0013355 W EP 0013355W WO 0150214 A2 WO0150214 A2 WO 0150214A2
Authority
WO
WIPO (PCT)
Prior art keywords
information
genetic material
individual
payment
supplier
Prior art date
Application number
PCT/EP2000/013355
Other languages
French (fr)
Other versions
WO2001050214A3 (en
Inventor
Ivo Van Den Maagdenberg
Christophe Van Huffel
Original Assignee
Starlab Nv/Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Starlab Nv/Sa filed Critical Starlab Nv/Sa
Priority to AU23709/01A priority Critical patent/AU2370901A/en
Publication of WO2001050214A2 publication Critical patent/WO2001050214A2/en
Publication of WO2001050214A3 publication Critical patent/WO2001050214A3/en

Links

Classifications

    • GPHYSICS
    • G06COMPUTING; CALCULATING OR COUNTING
    • G06QINFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR ADMINISTRATIVE, COMMERCIAL, FINANCIAL, MANAGERIAL OR SUPERVISORY PURPOSES; SYSTEMS OR METHODS SPECIALLY ADAPTED FOR ADMINISTRATIVE, COMMERCIAL, FINANCIAL, MANAGERIAL OR SUPERVISORY PURPOSES, NOT OTHERWISE PROVIDED FOR
    • G06Q30/00Commerce
    • G06Q30/02Marketing; Price estimation or determination; Fundraising
    • GPHYSICS
    • G16INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16BBIOINFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR GENETIC OR PROTEIN-RELATED DATA PROCESSING IN COMPUTATIONAL MOLECULAR BIOLOGY
    • G16B50/00ICT programming tools or database systems specially adapted for bioinformatics
    • G16B50/20Heterogeneous data integration
    • GPHYSICS
    • G16INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16BBIOINFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR GENETIC OR PROTEIN-RELATED DATA PROCESSING IN COMPUTATIONAL MOLECULAR BIOLOGY
    • G16B50/00ICT programming tools or database systems specially adapted for bioinformatics
    • G16B50/30Data warehousing; Computing architectures
    • GPHYSICS
    • G16INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16BBIOINFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR GENETIC OR PROTEIN-RELATED DATA PROCESSING IN COMPUTATIONAL MOLECULAR BIOLOGY
    • G16B50/00ICT programming tools or database systems specially adapted for bioinformatics

Definitions

  • This invention relates to methods, e.g., computer-based methods, for collecting information and material.
  • this invention relates to methods for collecting medical and genetic information and material.
  • the collections of genetic material currently held by pharmaceutical companies and other entities are, for the most part, obtained from isolated or narrowly specified populations, e.g., a population of individuals afflicted with a particular disease and their blood relatives or a population of individuals in a selected community or ethnic group. Accordingly, current collections of genetic material are generally derived from populations where a large founder effect is expected. It is rather unlikely that such collections of genetic material are representative of the worldwide population of disease related genes.
  • the analysis of collections of genetic material obtained from isolated populations has led to the identification of genes associated with several monogenic diseases. For example, researchers recently reported that mutations in a gene called AIRE are associated with autoimmune polyglandular syndrome type I (APS 1 ), a rare autosomal recessive disorder that maps to human chromosome 21.
  • Genetic information can be used to develop new diagnostic assays, new therapeutic regimes, and individually tailored therapeutic regimes. This genetics- based approach to disease diagnosis and treatment is widely expected to revolutionize health care. However, this genetic-based approach is likely to be fully realized only after sequencing significant portions of the genomes of a diverse population of individuals.
  • genetic material be first collected from a diverse population of individuals. It is important that the collected genetic material be associated with information about the individual from which it has been collected.
  • the associated information can include such basic information as the individual's age, gender, and place of residence. It can also include detailed medical information, both present and historical.
  • the present invention provides a method and system for an information collector to collect information from information suppliers and to provide an incentive for the information suppliers to provide the information.
  • the method and system are suitable for gathering many types of information, and are particularly useful for gathering information that increases in value over time or at least has the potential to increase in value over time.
  • the method of the invention which is typically implemented using a server computer system and a client computer system, entails rewarding each information supplier with an ownership share in value created by or associated with the information provided by the aggregate of information suppliers, e.g., by giving an information supplier with a ownership share or an option to purchase an ownership share in an entity having rights in the information provided by the information supplier.
  • the system and method of the invention can be implemented using a computer system accessible for on-line interactive communication.
  • the method of the invention makes it feasible for an information collector to obtain a considerable amount of information at relatively little present cost. This is particularly valuable where the value of the information provided by each information supplier is, at the time it is collected, of little value or an indeterminate value, at least to the information collector.
  • information that is of little value or indeterminate value to the information collector can be of value to the information supplier.
  • the information supplier may require an incentive, e.g., a payment, to provide the information to the information collector.
  • an incentive e.g., a payment
  • This disequilibrium makes it difficult to set a payment for the information supplied by an individual information supplier that is acceptable to both the information collector and the information supplier.
  • the methods of the invention address this problem by granting information suppliers an ownership share or an option on an ownership share in an entity having rights in the information collected.
  • the methods of the invention are quite useful where an information supplier requires or prefers an incentive to incur the cost of providing the information. This cost might be, e.g., the time required to provide the information, the loss of privacy associated with providing the information, or the loss of the exclusive use of the information.
  • An information supplier that is rewarded with an ownership share or an option on an ownership share in an entity having rights in the information collected has an incentive to provide complete and accurate information.
  • the information supplier has an ownership share in an entity or body of information which may grow in value over time, the information supplier has an incentive to both remain in contact with the information collector and to provide additional information.
  • the incentive given to an information supplier in exchange for the information provided is akin to an ownership share or an option on an ownership share in an entity that possesses or has rights in the provided information. Since the entity will typically possess information from a large number of individual suppliers and because the value of the aggregate information can be much higher than the value of the information obtained from each individual supplier or even the sum of the values of the information obtained from each of the individual suppliers, an ownership share in the entity can be of significant value. In addition, because the value of certain types of information grows over time, the providing of information in exchange for an ownership share or an option on an ownership share in the aggregate information can be a form of investment.
  • the method of the invention is used to obtain medical information and genetic material.
  • the method can be implemented using a computer system that includes a server system and a client system.
  • the method can be implemented using interconnected computers that exchange information using services such as electronic mail or the World Wide Web ("WWW").
  • WWW World Wide Web
  • the method of the invention can be implement by any means of communication, e.g., by conventional mail or by telephone.
  • a client system displays a questionnaire designed to elicit identification information and medical information from an information supplier, eg., in the form of a Web page which is sent from a server system to a client system.
  • the information supplier electronically completes or partially completes the questionnaire.
  • the information is sent from the client system to the server system, where it is analyzed for sufficiency.
  • the server system then issues an order to send a genetic material collection kit to the information supplier along with instructions for using the kit and returning the kit to an information collector.
  • the server system also issues a unique identifier which can be used to a associate the genetic material with the identification and medical information provided by the information supplier.
  • the "kit” can be sent electronically because it can be in the form of instructions for collecting and transmitting a biological sample containing DNA.
  • the genetic material can be any suitable biological sample, e.g., a sample of hair, blood or saliva.
  • the methods of the invention are particularly adapted to collecting this type of information. Although it is possible to sequence part or all of the DNA recovered from a small biological sample, it is not presently cost effective to sequence significant portions of the DNA obtained from a large number of individuals. However, automated sequencing methods will rapidly reduce the cost of carrying out such sequencing. This reduction in cost will make it feasible to sequence significant portions of the DNA of numerous individuals. Thus, the value of a collection of genetic material (i.e., biological material containing DNA) will increase in value.
  • the methods of the invention are useful for building a database of genetic material and rewarding the suppliers of the genetic material.
  • the suppliers of the genetic material and medical information by exchanging the genetic material and medical information for a share in the value of the aggregate information, are each making an investment in the value of a genetic database that will, over time, become increasingly useful in medical research and thus, increasingly valuable.
  • the invention features a method for obtaining genetic material from a plurality of individuals.
  • the methods includes: (a) providing on-line access to a questionnaire comprising a plurality of questions; (b) providing on-line access to a genetic material collection kit request form; (c) allowing an individual to electronically complete the questionnaire; (d) allowing an individual to electronically complete the genetic material collection kit request from; (e) in response to completion the request form, providing each individual with: (1) a genetic material collection kit including instructions for providing a sample of genetic material from the individual and transmitting the provided sample to a collector of genetic material; and (2) a unique identifier which matches the sample of genetic material to the completed questionnaire; and (f) obtaining the transmitted genetic material provided by the individual, whereby genetic material is obtained from the plurality of individuals.
  • the method includes making a payment to the individual upon obtaining the transmitted genetic material.
  • the payment can include an option to purchase an ownership share in an entity possessing the genetic material transmitted by the individual an ownership share in an entity possessing the genetic material provided by the individual, the payment to each individual comprising the plurality of individuals is the same, and the payment to at least a first individual in the plurality of individuals differs from the payment to a second individual in the plurality of individuals.
  • Figure 1 illustrates a system for collecting genetic and medical information.
  • Figure 2 illustrates a genetic material collection kit.
  • Figure 3 illustrates one embodiment of a hierarchical data entry form.
  • Figure 4 illustrates one embodiment of a hierarchical data entry form with the Identification Information section expanded (shown in part only).
  • Figure 5 illustrates one embodiment of a hierarchical data entry form with the Medical History section expanded (shown in part only).
  • the present invention provides a method and system for collecting information from information suppliers.
  • the system of the present invention provides an incentive for information suppliers to provide complete and accurate information and is particularly useful for obtaining information that is, at the time it is collected, of low or indeterminate value.
  • the system of the invention provides a cost-effective means for obtaining such information by exchanging the information for a payment that is linked, directly or indirectly, to either the value of the information provided by the information supplier or the aggregate value of the information provided by a plurality of information suppliers or both. This is accomplished, e.g., by granting information suppliers with an ownership share or an option on an ownership share in an entity having rights in the information collected or by granting information suppliers with an ownership share or an option on an ownership share in the mformation collected.
  • the value of the payment made to information suppliers can increase over time as well. Because the value of the information obtained from an individual can increase as the total number of individuals providing information grows, the value of the payment made to an individual can grow as additional individual information suppliers provide information.
  • FIG. 7 is a flow diagram illustrating an embodiment of the invention used to collect medical information and genetic material.
  • the information collector sends a medical questionnaire to a potential information supplier. This can be accomplished by causing a server computer system send a web page to a client computer system.
  • an information supplier completes the questionnaire, e.g., by completing data fields in web page sent to client computer system.
  • the information supplier returns the completed questionnaire to the information collector, e.g., by sending a electronic message to the server computer system.
  • the information collector sends a genetic sample collection kit to the information supplier.
  • the kit can be used to collect any biological sample containing the information supplier's DNA.
  • the kit can be used to collect a sample of hair, a sample of blood, or a sample of saliva.
  • the collection kit will be accompanied by instructions for collecting the sample.
  • the information supplier will be sent a unique identifier which is used to link the information provided in response to the questionnaire with the genetic material.
  • the genetic sample collection kit can be sent to the information supplier electronically, e.g., as a web page sent to a client server system. Such electronically transmitted kits are in the form of instructions for collecting a genetic sample.
  • the information supplier collects a genetic sample using the genetic sample kit.
  • the information supplier sends the collected genetic sample to the information collector.
  • the information collector issues a payment to the information supplier. This payment can include a share in or an option to purchase a share in an entity having rights in the information provided.
  • Figure 2 illustrates a simple genetic sample collection kit that can be electronically transmitted to an information supplier for collecting a sample of, e.g., saliva.
  • the kit is a piece of paper 210 marked with a target 220 for spitting onto.
  • the target 220 is sized such that when covered with saliva, sufficient DNA is deposited on the paper for extraction and sequencing.
  • the piece of paper 210 can be folded along lines 230 to protect the sample.
  • the piece of paper will also be marked with the unique identifier.
  • the marked piece of paper can be created by the information supplier using instructions transmitted electronically or can be printed from a web page transmitted to a client computer system.
  • the information supplier will be provided with instructions for collecting a saliva sample. For example, the supplier might be instructed to not collect the saliva sample immediately after food or beverage (other than water) intake.
  • the supplier might be instructed to drink a glass of water, wait five minutes, place the collection paper on a flat surface, spit onto the paper so as to fill the target with saliva, allow the saliva to dry, fold the paper, and place the folded paper in an envelope and send it to a particular address.
  • the data entry for the medical questionnaire as implemented on a Web page can be in the form of a hierarchical data entry form.
  • This type of form is useful where, as often the case, the entire questionnaire cannot fit on the user's display at one time without scrolling. When this happens, it can be difficult for the user to understand the nature and organization of the information to be entered. Moreover, completion of the questionnaire can appear to be a more difficult and time-consuming process than is actually the case.
  • Figure 3 illustrates one embodiment of a hierarchical data entry form with various sections identified by their title: Identification Information 301, Medical History 302, Medical History of Relatives 303, Environmental Information 304.
  • the Identification Information section 301 when the user selects the Identification Information section 301, that section expands to display data entry fields for basic identification information such as age 401, gender 402, height 403, weight 404, country of residence 405, country of birth 406, and e-mail address 407.
  • reply buttons e.g., for replying "yes” or "no” can be used in the place of a data entry field.
  • the other sections remain unexpanded, yet visible in title form 302, 303, and 304.
  • the user can click on the title of another section, e.g., the Medical History section 302.
  • the selected section will expand and the other sections will be visible in title form 301, 302, and 304.
  • Figure 5 illustrates a portion of the display when the Medical History section 302 has been expanded.
  • the Medical History section contains data entry fields for responding to inquiries about various medical conditions, e.g., speech impairment 501, hearing impairment 502, vision impairment 503, and diabetes 504.
  • Reply buttons can replace the data entry fields, as shown. Of course, may more questions can be asked. Replies to some questions, or even all questions, can be optional.
  • a payment can be made to the information supplier once the information has been sent to the information collector.
  • the payment can be in any form.
  • the preferred payment is an ownership share or an option to purchase an ownership share in an entity possessing or having rights in the information collected.
  • the value of the payment can vary. For example, an information supplier who provides very complete information could receive a payment that is greater than an information supplier who provides relatively incomplete information. For example an information supplier who provides relatively complete information could receive a lower cost option than an information supplier who provides less complete information. It might also be useful to vary the payment depending on the nature of the information provided. For example, in the context of medical information and genetic material, it might be relatively difficult to obtain information and material from individuals suffering from a relatively rare disease.
  • the medical information and genetic material obtained from these individuals can be of relatively high value. Accordingly, an information supplier suffering from a rare disease could receive a greater payment than one who does not. It may also be desirable to make the size of the payment dependent on the timing of the receipt of the information provided by the information supplier. For example, in order to give information suppliers an incentive for providing information at an early time, the payment given in exchange for the information provided could decrease over time. In a variation on this approach, the payment made to an information supplier would vary depending on how many information suppliers have already provided information. For example, an information supplier who provides information after 10,000 other information suppliers have already provided information might receive a lesser payment than an information supplier who provides information after only 1,000 other information suppliers have provided information.
  • identification information i.e., the information that could link the provider to the genetic material or to the medical information. Accordingly, the various databases can be maintained separately. In addition, a party that does not have access to the databases themselves could hold the identification codes which link identification information, medical information, and genetic material.
  • Those skilled in the art will be aware of various methods that can be used to protect the privacy of information suppliers. A number of embodiments of the mvention have been described. Nevertheless, it will be understood that various modifications may be made without departing from the spirit and scope of the invention. Accordingly, other embodiments are within the scope of the following claims.

Abstract

A method and system for an information collector to collect information from information suppliers and provide an incentive for the information suppliers to provide the information is described. The method and system are suitable for gathering many types of information, and are particularly useful for gathering information that increases in value over time or at least has the potential to increasing in value over time. The method of the invention, which is typically implemented using a server computer system and a client computer system, entails rewarding each information supplier with an ownership share in value created by or associated with the information provided by the aggregate of information suppliers.

Description

METHODS FOR COLLECTING GENETIC MATERIAL
TECHNICAL FIELD
This invention relates to methods, e.g., computer-based methods, for collecting information and material. In particular, this invention relates to methods for collecting medical and genetic information and material.
BACKGROUND
There is a growing consensus in the scientific community that many diseases have a genetic basis and that the variation from individual to individual in the severity of a given disease can be explained, at least in part, by genetic variation. The 60,000- 140,000 genes of the human genome are distributed over 3 billion bases of DNA. The genome displays considerable diversity. Current information indicates that approximately 0.1% of the bases in the genome differ between any two individuals (i.e., are polymorphic). Thus, developing an understanding of the genetic basis of any given disease may require sequencing several genes in a large population of individuals. The identification of genes and gene sequences associated with particular diseases is the first step in the development of new diagnostic assays and new therapeutic regimes.
The collections of genetic material currently held by pharmaceutical companies and other entities are, for the most part, obtained from isolated or narrowly specified populations, e.g., a population of individuals afflicted with a particular disease and their blood relatives or a population of individuals in a selected community or ethnic group. Accordingly, current collections of genetic material are generally derived from populations where a large founder effect is expected. It is rather unlikely that such collections of genetic material are representative of the worldwide population of disease related genes. The analysis of collections of genetic material obtained from isolated populations has led to the identification of genes associated with several monogenic diseases. For example, researchers recently reported that mutations in a gene called AIRE are associated with autoimmune polyglandular syndrome type I (APS 1 ), a rare autosomal recessive disorder that maps to human chromosome 21. However, the vast majority of diseases are multigenic and complex. In order to understand the genetic basis for such diseases, genetic material from significant number of individuals from diverse populations must be collected and analyzed. The analysis of such genetic material can lead to the identification of genes and particular gene sequences associated with various diseases. Larger and more diverse collections of genetic material are useful in other ways. For example, it is now recognized that a patient's response to a given therapeutic regime is, to some extent, dependent on the patient's genetic make-up. Thus, it can be desirable to tailor a patient's therapy to their genetic make-up. Doing so requires identifying the variations in gene sequence that are associated with a particular response to a therapeutic regime.
Genetic information can be used to develop new diagnostic assays, new therapeutic regimes, and individually tailored therapeutic regimes. This genetics- based approach to disease diagnosis and treatment is widely expected to revolutionize health care. However, this genetic-based approach is likely to be fully realized only after sequencing significant portions of the genomes of a diverse population of individuals.
Thus, it can be seen that in order to develop a greater understanding of most diseases and to develop diagnostic assays and safe and effective therapies for diseases, it is important that genetic material be first collected from a diverse population of individuals. It is important that the collected genetic material be associated with information about the individual from which it has been collected. The associated information can include such basic information as the individual's age, gender, and place of residence. It can also include detailed medical information, both present and historical.
There is a vast private and public effort underway to sequence the entire human genome, but in the short term the DNA of only a few individuals will be sequenced. Currently, there is no repository of genetic material and medical information available that will allow the human genome to effectively be accessed as universal information resource. Providing such a repository is an important step in hastening the coming health care revolution. SUMMARY
The present invention provides a method and system for an information collector to collect information from information suppliers and to provide an incentive for the information suppliers to provide the information. The method and system are suitable for gathering many types of information, and are particularly useful for gathering information that increases in value over time or at least has the potential to increase in value over time. The method of the invention, which is typically implemented using a server computer system and a client computer system, entails rewarding each information supplier with an ownership share in value created by or associated with the information provided by the aggregate of information suppliers, e.g., by giving an information supplier with a ownership share or an option to purchase an ownership share in an entity having rights in the information provided by the information supplier. The system and method of the invention can be implemented using a computer system accessible for on-line interactive communication.
The method of the invention makes it feasible for an information collector to obtain a considerable amount of information at relatively little present cost. This is particularly valuable where the value of the information provided by each information supplier is, at the time it is collected, of little value or an indeterminate value, at least to the information collector. Of course, information that is of little value or indeterminate value to the information collector can be of value to the information supplier. The information supplier may require an incentive, e.g., a payment, to provide the information to the information collector. As a result of these factors, there can arise a disequilibrium between the value to the information collector of the information provided by an individual information supplier and the value to the information supplier of the information provided. This disequilibrium makes it difficult to set a payment for the information supplied by an individual information supplier that is acceptable to both the information collector and the information supplier. The methods of the invention address this problem by granting information suppliers an ownership share or an option on an ownership share in an entity having rights in the information collected. The methods of the invention are quite useful where an information supplier requires or prefers an incentive to incur the cost of providing the information. This cost might be, e.g., the time required to provide the information, the loss of privacy associated with providing the information, or the loss of the exclusive use of the information.
An information supplier that is rewarded with an ownership share or an option on an ownership share in an entity having rights in the information collected has an incentive to provide complete and accurate information. In addition, because the information supplier has an ownership share in an entity or body of information which may grow in value over time, the information supplier has an incentive to both remain in contact with the information collector and to provide additional information.
In the preferred methods of the invention, the incentive given to an information supplier in exchange for the information provided is akin to an ownership share or an option on an ownership share in an entity that possesses or has rights in the provided information. Since the entity will typically possess information from a large number of individual suppliers and because the value of the aggregate information can be much higher than the value of the information obtained from each individual supplier or even the sum of the values of the information obtained from each of the individual suppliers, an ownership share in the entity can be of significant value. In addition, because the value of certain types of information grows over time, the providing of information in exchange for an ownership share or an option on an ownership share in the aggregate information can be a form of investment.
In one embodiment, the method of the invention is used to obtain medical information and genetic material. The method can be implemented using a computer system that includes a server system and a client system. For example, the method can be implemented using interconnected computers that exchange information using services such as electronic mail or the World Wide Web ("WWW"). However, the method of the invention can be implement by any means of communication, e.g., by conventional mail or by telephone. In one embodiment, a client system displays a questionnaire designed to elicit identification information and medical information from an information supplier, eg., in the form of a Web page which is sent from a server system to a client system. The information supplier electronically completes or partially completes the questionnaire. The information is sent from the client system to the server system, where it is analyzed for sufficiency. The server system then issues an order to send a genetic material collection kit to the information supplier along with instructions for using the kit and returning the kit to an information collector. The server system also issues a unique identifier which can be used to a associate the genetic material with the identification and medical information provided by the information supplier. The "kit" can be sent electronically because it can be in the form of instructions for collecting and transmitting a biological sample containing DNA. The genetic material can be any suitable biological sample, e.g., a sample of hair, blood or saliva.
The methods of the invention are particularly adapted to collecting this type of information. Although it is possible to sequence part or all of the DNA recovered from a small biological sample, it is not presently cost effective to sequence significant portions of the DNA obtained from a large number of individuals. However, automated sequencing methods will rapidly reduce the cost of carrying out such sequencing. This reduction in cost will make it feasible to sequence significant portions of the DNA of numerous individuals. Thus, the value of a collection of genetic material (i.e., biological material containing DNA) will increase in value. The methods of the invention are useful for building a database of genetic material and rewarding the suppliers of the genetic material. In essence the suppliers of the genetic material and medical information, by exchanging the genetic material and medical information for a share in the value of the aggregate information, are each making an investment in the value of a genetic database that will, over time, become increasingly useful in medical research and thus, increasingly valuable. Thus, the invention features a method for obtaining genetic material from a plurality of individuals. The methods includes: (a) providing on-line access to a questionnaire comprising a plurality of questions; (b) providing on-line access to a genetic material collection kit request form; (c) allowing an individual to electronically complete the questionnaire; (d) allowing an individual to electronically complete the genetic material collection kit request from; (e) in response to completion the request form, providing each individual with: (1) a genetic material collection kit including instructions for providing a sample of genetic material from the individual and transmitting the provided sample to a collector of genetic material; and (2) a unique identifier which matches the sample of genetic material to the completed questionnaire; and (f) obtaining the transmitted genetic material provided by the individual, whereby genetic material is obtained from the plurality of individuals.
In a preferred embodiment, the method includes making a payment to the individual upon obtaining the transmitted genetic material. In various embodiments the payment can include an option to purchase an ownership share in an entity possessing the genetic material transmitted by the individual an ownership share in an entity possessing the genetic material provided by the individual, the payment to each individual comprising the plurality of individuals is the same, and the payment to at least a first individual in the plurality of individuals differs from the payment to a second individual in the plurality of individuals.
The details of one or more embodiments of the invention are set forth in the accompanying drawings and the description below. Other features, objects, and advantages of the invention will be apparent from the description and drawings, and from the claims.
DESCRIPTION OF DRAWINGS
Figure 1 illustrates a system for collecting genetic and medical information. Figure 2 illustrates a genetic material collection kit.
Figure 3 illustrates one embodiment of a hierarchical data entry form. Figure 4 illustrates one embodiment of a hierarchical data entry form with the Identification Information section expanded (shown in part only).
Figure 5 illustrates one embodiment of a hierarchical data entry form with the Medical History section expanded (shown in part only).
Like reference symbols in the various drawings indicate like elements.
DETAILED DESCRIPTION
The present invention provides a method and system for collecting information from information suppliers. The system of the present invention provides an incentive for information suppliers to provide complete and accurate information and is particularly useful for obtaining information that is, at the time it is collected, of low or indeterminate value. The system of the invention provides a cost-effective means for obtaining such information by exchanging the information for a payment that is linked, directly or indirectly, to either the value of the information provided by the information supplier or the aggregate value of the information provided by a plurality of information suppliers or both. This is accomplished, e.g., by granting information suppliers with an ownership share or an option on an ownership share in an entity having rights in the information collected or by granting information suppliers with an ownership share or an option on an ownership share in the mformation collected.
Because the value of certain types of information grows over time, the value of the payment made to information suppliers can increase over time as well. Because the value of the information obtained from an individual can increase as the total number of individuals providing information grows, the value of the payment made to an individual can grow as additional individual information suppliers provide information.
Figure 7 is a flow diagram illustrating an embodiment of the invention used to collect medical information and genetic material. In step 201, the information collector sends a medical questionnaire to a potential information supplier. This can be accomplished by causing a server computer system send a web page to a client computer system. In step 202 an information supplier completes the questionnaire, e.g., by completing data fields in web page sent to client computer system. In step 203 the information supplier returns the completed questionnaire to the information collector, e.g., by sending a electronic message to the server computer system. In step 204 the information collector sends a genetic sample collection kit to the information supplier. The kit can be used to collect any biological sample containing the information supplier's DNA. For example, the kit can be used to collect a sample of hair, a sample of blood, or a sample of saliva. In many embodiments the collection kit will be accompanied by instructions for collecting the sample. In addition to the genetic sample collection kit, the information supplier will be sent a unique identifier which is used to link the information provided in response to the questionnaire with the genetic material. Importantly, the genetic sample collection kit can be sent to the information supplier electronically, e.g., as a web page sent to a client server system. Such electronically transmitted kits are in the form of instructions for collecting a genetic sample. In step 205 the information supplier collects a genetic sample using the genetic sample kit. In step 206 the information supplier sends the collected genetic sample to the information collector. In step 207 the information collector issues a payment to the information supplier. This payment can include a share in or an option to purchase a share in an entity having rights in the information provided.
Figure 2 illustrates a simple genetic sample collection kit that can be electronically transmitted to an information supplier for collecting a sample of, e.g., saliva. The kit is a piece of paper 210 marked with a target 220 for spitting onto. The target 220 is sized such that when covered with saliva, sufficient DNA is deposited on the paper for extraction and sequencing. The piece of paper 210 can be folded along lines 230 to protect the sample. The piece of paper will also be marked with the unique identifier. The marked piece of paper can be created by the information supplier using instructions transmitted electronically or can be printed from a web page transmitted to a client computer system. The information supplier will be provided with instructions for collecting a saliva sample. For example, the supplier might be instructed to not collect the saliva sample immediately after food or beverage (other than water) intake. The supplier might be instructed to drink a glass of water, wait five minutes, place the collection paper on a flat surface, spit onto the paper so as to fill the target with saliva, allow the saliva to dry, fold the paper, and place the folded paper in an envelope and send it to a particular address.
The data entry for the medical questionnaire as implemented on a Web page can be in the form of a hierarchical data entry form. This type of form is useful where, as often the case, the entire questionnaire cannot fit on the user's display at one time without scrolling. When this happens, it can be difficult for the user to understand the nature and organization of the information to be entered. Moreover, completion of the questionnaire can appear to be a more difficult and time-consuming process than is actually the case. Figure 3 illustrates one embodiment of a hierarchical data entry form with various sections identified by their title: Identification Information 301, Medical History 302, Medical History of Relatives 303, Environmental Information 304. As shown in Figure 4, when the user selects the Identification Information section 301, that section expands to display data entry fields for basic identification information such as age 401, gender 402, height 403, weight 404, country of residence 405, country of birth 406, and e-mail address 407. In some cases reply buttons, e.g., for replying "yes" or "no" can be used in the place of a data entry field.
When the Identification Information section is expanded, the other sections remain unexpanded, yet visible in title form 302, 303, and 304. Once the user has completed one section, e.g., the Identification Information section, the user can click on the title of another section, e.g., the Medical History section 302. The selected section will expand and the other sections will be visible in title form 301, 302, and 304.
Figure 5 illustrates a portion of the display when the Medical History section 302 has been expanded. The Medical History section contains data entry fields for responding to inquiries about various medical conditions, e.g., speech impairment 501, hearing impairment 502, vision impairment 503, and diabetes 504. Reply buttons can replace the data entry fields, as shown. Of course, may more questions can be asked. Replies to some questions, or even all questions, can be optional.
A payment can be made to the information supplier once the information has been sent to the information collector. The payment can be in any form. The preferred payment is an ownership share or an option to purchase an ownership share in an entity possessing or having rights in the information collected. The value of the payment can vary. For example, an information supplier who provides very complete information could receive a payment that is greater than an information supplier who provides relatively incomplete information. For example an information supplier who provides relatively complete information could receive a lower cost option than an information supplier who provides less complete information. It might also be useful to vary the payment depending on the nature of the information provided. For example, in the context of medical information and genetic material, it might be relatively difficult to obtain information and material from individuals suffering from a relatively rare disease. As a result, the medical information and genetic material obtained from these individuals can be of relatively high value. Accordingly, an information supplier suffering from a rare disease could receive a greater payment than one who does not. It may also be desirable to make the size of the payment dependent on the timing of the receipt of the information provided by the information supplier. For example, in order to give information suppliers an incentive for providing information at an early time, the payment given in exchange for the information provided could decrease over time. In a variation on this approach, the payment made to an information supplier would vary depending on how many information suppliers have already provided information. For example, an information supplier who provides information after 10,000 other information suppliers have already provided information might receive a lesser payment than an information supplier who provides information after only 1,000 other information suppliers have provided information.
Some information providers may have privacy concerns and may prefer that the identification information (i.e., the information that could link the provider to the genetic material or to the medical information). Accordingly, the various databases can be maintained separately. In addition, a party that does not have access to the databases themselves could hold the identification codes which link identification information, medical information, and genetic material. Those skilled in the art will be aware of various methods that can be used to protect the privacy of information suppliers. A number of embodiments of the mvention have been described. Nevertheless, it will be understood that various modifications may be made without departing from the spirit and scope of the invention. Accordingly, other embodiments are within the scope of the following claims.

Claims

WHAT IS CLAIMED IS:
1. A method for obtaining genetic material from a plurality of individuals, comprising:
(a) providing access to a questionnaire comprising a plurality of questions;
(b) providing access to a genetic material collection kit request form; (c) allowing an individual to electronically complete the questionnaire;
(d) allowing an individual to electronically complete the genetic material collection kit request from;
(e) in response to completion the request form, providing each individual with: (1) a genetic material collection kit including instructions for providing a sample of genetic material from the individual and transmitting the provided sample to a collector of genetic material; and
(2) a unique identifier which matches the sample of genetic material to the completed questionnaire; (f) obtaining the transmitted genetic material provided by the individual, whereby genetic material is obtained from the plurality of individuals.
2. The method of claim 1 further comprising:
(g) making a payment to the individual upon obtaining the transmitted genetic material.
3. The method of claim 2 wherein the payment comprises an option to purchase an ownership share in an entity possessing the genetic material transmitted by the individual.
4. The method of claim 2 wherein the payment comprises an ownership share in an entity possessing the genetic material transmitted by the individual.
5. The method of claim 2 wherein the payment to each individual comprising the plurality of individuals is the same.
6. The method of claim 2 wherein the payment to at least a first individual in the plurality of individuals differs from the payment to a second individual in the plurality of individuals.
PCT/EP2000/013355 1999-12-30 2000-12-27 Methods for collecting genetic material WO2001050214A2 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
AU23709/01A AU2370901A (en) 1999-12-30 2000-12-27 Methods for collecting genetic material

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US47554099A 1999-12-30 1999-12-30
US09/475,540 1999-12-30

Publications (2)

Publication Number Publication Date
WO2001050214A2 true WO2001050214A2 (en) 2001-07-12
WO2001050214A3 WO2001050214A3 (en) 2002-06-13

Family

ID=23888030

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/EP2000/013355 WO2001050214A2 (en) 1999-12-30 2000-12-27 Methods for collecting genetic material

Country Status (2)

Country Link
AU (1) AU2370901A (en)
WO (1) WO2001050214A2 (en)

Cited By (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7797302B2 (en) 2007-03-16 2010-09-14 Expanse Networks, Inc. Compiling co-associating bioattributes
US8788286B2 (en) 2007-08-08 2014-07-22 Expanse Bioinformatics, Inc. Side effects prediction using co-associating bioattributes
US9031870B2 (en) 2008-12-30 2015-05-12 Expanse Bioinformatics, Inc. Pangenetic web user behavior prediction system
US10726098B2 (en) 2014-01-23 2020-07-28 Dror Samuel Brama Method, system and program product for transferring genetic and health data
US11657902B2 (en) 2008-12-31 2023-05-23 23Andme, Inc. Finding relatives in a database

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2001031551A1 (en) * 1999-10-22 2001-05-03 First Genetic Trust, Inc. Genetic profiling and banking system and method

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2001031551A1 (en) * 1999-10-22 2001-05-03 First Genetic Trust, Inc. Genetic profiling and banking system and method

Non-Patent Citations (2)

* Cited by examiner, † Cited by third party
Title
"Act on a health sector database 139/98" MINSITRY OF HEALTH AND SOCIAL SECURITY, [Online] October 1998 (1998-10), XP002193882 Retrieved from the Internet: <URL:http://brunnur.stjr.is/interpro/htr/h tr.nsf/pages/gagngr-log-ensk> [retrieved on 2002-03-21] *
GULCHER J ET AL: "POPULATION GENOMICS: LAYING THE GROUNDWORK FOR GENETIC DISEASE MODELING AND TARGETING" CLINICAL CHEMISTRY AND LABORATORY MEDICINE, WALTER DE GRUYTER UND CO, DE, vol. 36, no. 8, 1998, pages 523-527, XP002941805 ISSN: 1434-6621 *

Cited By (35)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US10957455B2 (en) 2007-03-16 2021-03-23 Expanse Bioinformatics, Inc. Computer implemented identification of genetic similarity
US7941434B2 (en) 2007-03-16 2011-05-10 Expanse Networks, Inc. Efficiently compiling co-associating bioattributes
US7933912B2 (en) 2007-03-16 2011-04-26 Expanse Networks, Inc. Compiling co-associating bioattributes using expanded bioattribute profiles
US10991467B2 (en) 2007-03-16 2021-04-27 Expanse Bioinformatics, Inc. Treatment determination and impact analysis
US7941329B2 (en) 2007-03-16 2011-05-10 Expanse Networks, Inc. Insurance optimization and longevity analysis
US7797302B2 (en) 2007-03-16 2010-09-14 Expanse Networks, Inc. Compiling co-associating bioattributes
US8051033B2 (en) 2007-03-16 2011-11-01 Expanse Networks, Inc. Predisposition prediction using attribute combinations
US8099424B2 (en) 2007-03-16 2012-01-17 Expanse Networks, Inc. Treatment determination and impact analysis
US8209319B2 (en) 2007-03-16 2012-06-26 Expanse Networks, Inc. Compiling co-associating bioattributes
US8606761B2 (en) 2007-03-16 2013-12-10 Expanse Bioinformatics, Inc. Lifestyle optimization and behavior modification
US11735323B2 (en) 2007-03-16 2023-08-22 23Andme, Inc. Computer implemented identification of genetic similarity
US11621089B2 (en) 2007-03-16 2023-04-04 23Andme, Inc. Attribute combination discovery for predisposition determination of health conditions
US10379812B2 (en) 2007-03-16 2019-08-13 Expanse Bioinformatics, Inc. Treatment determination and impact analysis
US11600393B2 (en) 2007-03-16 2023-03-07 23Andme, Inc. Computer implemented modeling and prediction of phenotypes
US10803134B2 (en) 2007-03-16 2020-10-13 Expanse Bioinformatics, Inc. Computer implemented identification of genetic similarity
US10896233B2 (en) 2007-03-16 2021-01-19 Expanse Bioinformatics, Inc. Computer implemented identification of genetic similarity
US11791054B2 (en) 2007-03-16 2023-10-17 23Andme, Inc. Comparison and identification of attribute similarity based on genetic markers
US7818310B2 (en) 2007-03-16 2010-10-19 Expanse Networks, Inc. Predisposition modification
US8024348B2 (en) 2007-03-16 2011-09-20 Expanse Networks, Inc. Expanding attribute profiles
US11348692B1 (en) 2007-03-16 2022-05-31 23Andme, Inc. Computer implemented identification of modifiable attributes associated with phenotypic predispositions in a genetics platform
US11348691B1 (en) 2007-03-16 2022-05-31 23Andme, Inc. Computer implemented predisposition prediction in a genetics platform
US11482340B1 (en) 2007-03-16 2022-10-25 23Andme, Inc. Attribute combination discovery for predisposition determination of health conditions
US11495360B2 (en) 2007-03-16 2022-11-08 23Andme, Inc. Computer implemented identification of treatments for predicted predispositions with clinician assistance
US11581098B2 (en) 2007-03-16 2023-02-14 23Andme, Inc. Computer implemented predisposition prediction in a genetics platform
US11515047B2 (en) 2007-03-16 2022-11-29 23Andme, Inc. Computer implemented identification of modifiable attributes associated with phenotypic predispositions in a genetics platform
US11545269B2 (en) 2007-03-16 2023-01-03 23Andme, Inc. Computer implemented identification of genetic similarity
US11581096B2 (en) 2007-03-16 2023-02-14 23Andme, Inc. Attribute identification based on seeded learning
US8788286B2 (en) 2007-08-08 2014-07-22 Expanse Bioinformatics, Inc. Side effects prediction using co-associating bioattributes
US11514085B2 (en) 2008-12-30 2022-11-29 23Andme, Inc. Learning system for pangenetic-based recommendations
US9031870B2 (en) 2008-12-30 2015-05-12 Expanse Bioinformatics, Inc. Pangenetic web user behavior prediction system
US11003694B2 (en) 2008-12-30 2021-05-11 Expanse Bioinformatics Learning systems for pangenetic-based recommendations
US11657902B2 (en) 2008-12-31 2023-05-23 23Andme, Inc. Finding relatives in a database
US11776662B2 (en) 2008-12-31 2023-10-03 23Andme, Inc. Finding relatives in a database
US11935628B2 (en) 2008-12-31 2024-03-19 23Andme, Inc. Finding relatives in a database
US10726098B2 (en) 2014-01-23 2020-07-28 Dror Samuel Brama Method, system and program product for transferring genetic and health data

Also Published As

Publication number Publication date
AU2370901A (en) 2001-07-16
WO2001050214A3 (en) 2002-06-13

Similar Documents

Publication Publication Date Title
US20170372015A1 (en) Transfusion Registry Network Providing Real-time Interaction Between Users and Providers of Genetically Characterized Blood Products
US5985559A (en) System and method for preventing, diagnosing, and treating genetic and pathogen-caused disease
US7856456B2 (en) System and method for electronically managing medical data files
US20120203466A1 (en) System and method for identifying disease-influencing genes
US8571810B2 (en) Information processing system using nucleotide sequence-related information
US20060200319A1 (en) System and method for identifying disease-influencing genes
Collin et al. Homozygosity mapping of Alström syndrome to chromosome 2p
Castellino When the chips are down
JPH11501741A (en) Computer system for storing and analyzing microbiological data
US20020082869A1 (en) Method and system for providing and updating customized health care information based on an individual&#39;s genome
WO2003009210A1 (en) Methods of providing customized gene annotation reports
US20090240441A1 (en) System and method for analysis and presentation of genomic data
TW473684B (en) Method and system for providing genotype clinical information over a computer network
WO2001050214A2 (en) Methods for collecting genetic material
US20080154643A1 (en) System and Method for Patient Management of Personal Health
WO2004086274A1 (en) System and method for providing health information using genome information
Cordeiro et al. The GM2 gangliosidoses datanases: Allelic variation at the HEXA, HEXB, and GMWA gene loci
Hershorn The elusive population: Characteristics of attenders versus non-attenders for community mental health center intakes
JP2004005248A (en) Body information management system
CA2494360A1 (en) Molecular timetable generating apparatus and internal biological clock estimating apparatus
Ouellette Internet resources for the clinical geneticist
JP3324594B2 (en) Bio product quality assurance method and bio information distribution method
Tarczy-Hornoch et al. Creation and maintenance of Helix, a Web based database of medical genetics laboratories, to serve the needs of the genetics community.
Xiao et al. Parent Knowledge of Screening and Genetic Testing in Retinoblastoma
Wallace The potential of population surveys for genetic studies

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A2

Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY BZ CA CH CN CR CU CZ DE DK DM DZ EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NO NZ PL PT RO RU SD SE SG SI SK SL TJ TM TR TT TZ UA UG US UZ VN YU ZA ZW

AL Designated countries for regional patents

Kind code of ref document: A2

Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE TR BF BJ CF CG CI CM GA GN GW ML MR NE SN TD TG

121 Ep: the epo has been informed by wipo that ep was designated in this application
DFPE Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101)
AK Designated states

Kind code of ref document: A3

Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY BZ CA CH CN CR CU CZ DE DK DM DZ EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NO NZ PL PT RO RU SD SE SG SI SK SL TJ TM TR TT TZ UA UG US UZ VN YU ZA ZW

AL Designated countries for regional patents

Kind code of ref document: A3

Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE TR BF BJ CF CG CI CM GA GN GW ML MR NE SN TD TG

REG Reference to national code

Ref country code: DE

Ref legal event code: 8642

32PN Ep: public notification in the ep bulletin as address of the adressee cannot be established

Free format text: NOTING OF LOSS OF RIGHTS PURSUANT TO RULE 69(1) EPC (EPO COMMUNICATION= FORM 1205A DATED: 11.06.2003)

122 Ep: pct application non-entry in european phase
NENP Non-entry into the national phase

Ref country code: JP